These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31554947)

  • 21. Does the number of laser applications for ROP treatment influence the degree of myopia?
    Inoue T; Asaoka R; Hashimoto Y; Kitamoto K; Kitano M; Fujita A; Azuma K; Yamamoto K; Nagahara M; Kadonosono K; Obata R
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):317-322. PubMed ID: 32978662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior zone I retinopathy of prematurity: spectrum of disease and outcome after laser treatment.
    Katoch D; Dogra MR; Aggarwal K; Sanghi G; Samanta R; Handa S; Dogra M
    Can J Ophthalmol; 2019 Feb; 54(1):87-93. PubMed ID: 30851780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.
    Kabataş EU; Kurtul BE; Altıaylık Özer P; Kabataş N
    Curr Eye Res; 2017 Jul; 42(7):1054-1058. PubMed ID: 28128986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
    Gunay M; Sukgen EA; Celik G; Kocluk Y
    Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity.
    Dhawan A; Dogra M; Vinekar A; Gupta A; Dutta S
    J Pediatr Ophthalmol Strabismus; 2008; 45(6):356-61. PubMed ID: 19043947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.
    Quinn GE; Dobson V; Siatkowski R; Hardy RJ; Kivlin J; Palmer EA; Phelps DL; Repka MX; Summers CG; Tung B; Chan W;
    Ophthalmology; 2001 Feb; 108(2):343-7. PubMed ID: 11158812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
    Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
    Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diode laser treatment of pre-threshold and threshold retinopathy of prematurity.
    Lee GA; Hilford DJ; Gole GA
    Clin Exp Ophthalmol; 2004 Apr; 32(2):164-9. PubMed ID: 15068433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome.
    Connolly BP; Ng EY; McNamara JA; Regillo CD; Vander JF; Tasman W
    Ophthalmology; 2002 May; 109(5):936-41. PubMed ID: 11986101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular growth and refractive error development in premature infants with or without retinopathy of prematurity.
    Cook A; White S; Batterbury M; Clark D
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5199-207. PubMed ID: 19036998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of laser versus lens-sparing vitrectomy on myopia in children with retinopathy of prematurity.
    Agarkar S; Desai R; Singh S; Jaisankar D; Bhende P; Raman R
    Indian J Ophthalmol; 2017 Sep; 65(9):841-845. PubMed ID: 28905828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for early-onset high myopia after treatment for retinopathy of prematurity.
    Matsumura S; Matsumoto T; Katayama Y; Tomita M; Morikawa H; Itokawa T; Kawakami M; Hori Y
    Jpn J Ophthalmol; 2022 Jul; 66(4):386-393. PubMed ID: 35488107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome.
    Shalev B; Farr AK; Repka MX
    Am J Ophthalmol; 2001 Jul; 132(1):76-80. PubMed ID: 11438057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy.
    Hondur AM; Çubuk MÖ; Özen Tunay Z; Atalay HT; Özdemir Ö; Petriçli İS; Gürelik İG
    Turk J Med Sci; 2016 Apr; 46(3):764-8. PubMed ID: 27513253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity.
    Gunay M; Celik G; Gunay BO; Aktas A; Karatekin G; Ovali F
    Arq Bras Oftalmol; 2015; 78(5):300-4. PubMed ID: 26466229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
    Huang ZN; Yin DM; Huang DR; Liang SX
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
    Onofrey CB; Feuer WJ; Flynn JT
    Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diode laser photocoagulation posterior to the ridge in severe stage 3+ threshold retinopathy of prematurity.
    Arvas S; Sarici AM; Akar S
    Cutan Ocul Toxicol; 2014 Sep; 33(3):197-200. PubMed ID: 24147941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laser photocoagulation for retinopathy of prematurity: structural and functional outcome.
    Kieselbach GF; Ramharter A; Baldissera I; Kralinger MT
    Acta Ophthalmol Scand; 2006 Feb; 84(1):21-6. PubMed ID: 16445435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The results of diode treatment of active phase of retinopathy of prematurity].
    Gotz-Wieckowska A; Kociecki J; Burchardt-Kroll E; Gadzinowski J
    Klin Oczna; 2003; 105(6):395-7. PubMed ID: 15049263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.